Indicators

Markets:

News

Latest News about NBIX

Recent news which mentions NBIX

< Previous 1 2 3 4 5 6 Next >

Confidence Boost From Ingrezza Sales: Analyst Upgrades Neurocrine Biosciences

July 06, 2023

What To Know About BMO Capital's Upgrade of Neurocrine Biosciences

July 06, 2023

Benzinga's Top Ratings Upgrades, Downgrades For July 6, 2023

July 06, 2023

Expert Ratings for Neurocrine Biosciences

June 30, 2023

What 15 Analyst Ratings Have To Say About Neurocrine Biosciences

June 05, 2023

Neurocrine Biosciences's Return On Capital Employed Overview

May 08, 2023

Benzinga's Top Ratings Upgrades, Downgrades For May 4, 2023

May 04, 2023

Neurocrine Biosciences Clocks 35% Revenue Growth In Q1, Misses On Bottom-Line Performance

May 03, 2023

Neurocrine Biosciences: Q1 Earnings Insights

May 03, 2023

Neurocrine Biosciences's Earnings: A Preview

May 02, 2023

3 Pharma Stocks That Could See a Surge in Demand in 2023

April 24, 2023

What 15 Analyst Ratings Have To Say About Neurocrine Biosciences

April 17, 2023

Expert Ratings for Neurocrine Biosciences

March 30, 2023

Benzinga's Top Ratings Upgrades, Downgrades For March 30, 2023

March 30, 2023

3 Growth Stocks That Could Disrupt the Healthcare Industry

March 13, 2023

Analyst Expectations for Neurocrine Biosciences's Future

March 03, 2023

Benzinga's Top Ratings Upgrades, Downgrades For March 3, 2023

March 03, 2023

Earnings Scheduled For February 6, 2023

February 06, 2023

Neurocrine Biosciences Earnings Preview

February 03, 2023

Benzinga's Top Ratings Upgrades, Downgrades For February 3, 2023

February 03, 2023

Analyst Views Karuna Therapeutics' New Licensing Deal 'As Intriguing'

February 03, 2023

7 A-Rated Stocks to Buy for Less Than $25

January 24, 2023

Why Voyager Therapeutics Stock Is Sinking This Week

January 20, 2023

Voyager Therapeutics (VYGR) Stock Gains 18% on Gene Therapy Deal

January 09, 2023

Neurocrine Biosciences, Voyager Therapeutics Collaborate For Neurological-Focused Gene Therapies

January 09, 2023

Have A Look At William Blair's Top Biotech Picks For 2023

December 25, 2022

Despite Neurocrine's Epilepsy Drug Missing Primary Goal In Pediatric Trial, Analyst Sees Strong Growth

December 07, 2022

Stocks That Hit 52-Week Lows On Thursday

December 01, 2022

How to Trade the High-Growth Biotech Sector in the Midst of a Bear Market

November 23, 2022

Heska To $165? Plus BTIG Cuts PT On This Stock By 67%

November 14, 2022

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.